본문 바로가기
KERD
논문KCI 등재

Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: Recent studies have revealed that a small subset of Lynch syndrome-associated colorectal carcinomas (CRCs) is caused by a germline EPCAM deletion-induced MSH2 epimutation. Based on the finding of this genetic alteration, we investigated the implications of EPCAM expression changes in microsatellite instability-high (MSI-H) CRCs. Methods: Expression of EPCAM and DNA mismatch repair proteins was assessed by immunohistochemistry in 168 MSI-H CRCs. Using DNA samples of these tumors, MLH1 promoter methylation status was also determined by methylation-specific real-time polymerase chain reaction method (MethyLight). Results: Among 168 MSI-H CRCs, complete loss (CL) and focal loss (FL) of EPCAM expression was observed in two (1.2%) and 22 (13.1%) cases, respectively. Both of the EPCAM-CL cases were found in MSH2-negative tumors without MLH1 promoter methylation. However, only nine of the 22 EPCAM-FL tumors had MSH2 deficiency. Of the 22 EPCAM-FL tumors, 13 showed MLH1 loss, and among them, nine cases were determined to have MLH1 methylation. EPCAM-FL was significantly associated with advanced stage (p=.043), distant metastasis (p=.003), poor differentiation (p=.001), and signet ring cell component (p=.004). Conclusions: Loss of EPCAM expression is differentially associated with clinicopathological and molecular features, depending on the completeness of the loss, in MSI-H CRCs.

Abstract

Background: Recent studies have revealed that a small subset of Lynch syndrome-associated colorectal carcinomas (CRCs) is caused by a germline EPCAM deletion-induced MSH2 epimutation. Based on the finding of this genetic alteration, we investigated the implications of EPCAM expression changes in microsatellite instability-high (MSI-H) CRCs. Methods: Expression of EPCAM and DNA mismatch repair proteins was assessed by immunohistochemistry in 168 MSI-H CRCs. Using DNA samples of these tumors, MLH1 promoter methylation status was also determined by methylation-specific real-time polymerase chain reaction method (MethyLight). Results: Among 168 MSI-H CRCs, complete loss (CL) and focal loss (FL) of EPCAM expression was observed in two (1.2%) and 22 (13.1%) cases, respectively. Both of the EPCAM-CL cases were found in MSH2-negative tumors without MLH1 promoter methylation. However, only nine of the 22 EPCAM-FL tumors had MSH2 deficiency. Of the 22 EPCAM-FL tumors, 13 showed MLH1 loss, and among them, nine cases were determined to have MLH1 methylation. EPCAM-FL was significantly associated with advanced stage (p=.043), distant metastasis (p=.003), poor differentiation (p=.001), and signet ring cell component (p=.004). Conclusions: Loss of EPCAM expression is differentially associated with clinicopathological and molecular features, depending on the completeness of the loss, in MSI-H CRCs.

참고문헌 (20)

  1. Bosman FT, "WHO classification of tumours of the digestive system" (2010), IARC Press
  2. Boland CR, "Microsatellite instability in colorectal cancer", Gastroenterology, 138, pp.2073~2087.e3 (2010)
  3. de la Chapelle A, "Clinical relevance of microsatellite instability in colorectal cancer", J Clin Oncol, 28, pp.3380~3387 (2010)
  4. Pino MS, "Microsatellite instability in the management of colorectal cancer", Expert Rev Gastroenterol Hepatol, 5, pp.385~399 (2011)
  5. Ligtenberg MJ, "Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3’ exons of TACSTD1", Nat Genet, 41, pp.112~117 (2009)
  6. Chan TL, "Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer", Nat Genet, 38, pp.1178~1183 (2006)
  7. Tutlewska K, "Germline deletions in the EPCAM gene as a cause of Lynch syndrome: literature review", Hered Cancer Clin Pract, 11, pp.9~ (2013)
  8. Ligtenberg MJ, "EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients", Fam Cancer, 12, pp.169~174 (2013)
  9. Kloor M, "Analysis of EPCAM protein expression in diagnostics of Lynch syndrome", J Clin Oncol, 29, pp.223~227 (2011)
  10. Huth C, "The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors", Mod Pathol, 25, pp.911~916 (2012)
  11. Musulen E, "Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification", Hum Pathol, 44, pp.412~416 (2013)
  12. Kim JH, "Expression status of wild-type HSP110 correlates with HSP110 T17 deletion size and patient prognosis in microsatellite-unstable colorectal cancer", Modern Pathology, 27(3), pp.443~453 (2014), Nature Publishing Group
  13. Boland CR, "A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer", Cancer Res, 58, pp.5248~5257 (1998)
  14. 김정호, "Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status", Modern Pathology, 26(7), pp.1013~1022 (2013), Nature Publishing Group
  15. Weisenberger DJ, "CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer", Nat Genet, 38, pp.787~793 (2006)
  16. Patriarca C, "Epithelial cell adhesion molecule expression (CD326) in cancer: a short review", Cancer Treat Rev, 38, pp.68~75 (2012)
  17. Carella R, "Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis", Am J Surg Pathol, 25, pp.43~50 (2001)
  18. Imrich S, "EpCAM and its potential role in tumor-initiating cells", Cell Adh Migr, 6, pp.30~38 (2012)
  19. Yamashita T, "EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem", progenitor cell features, 2009, pp.136, 1012~1024
  20. Bae JM, "Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status", Virchows Arch, 459, pp.55~63 (2011)

관련 논문AI추천

Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer오훈규, 전창호, 정상봉, Han-IL Lee, Im-Hee Shin,대한암학회 · Cancer Research and Treatment2012 · 제44권 제3호Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry강영진, 김어진, 김주영, 김철환, 안보경, 이영석, 이유진, 이은정, 이정현, 정지윤, 채양석대한병리학회 · Journal of Pathology and Translational Medicine2017 · 제51권 제2호Clinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability김상겸, 김현기, 김호근, 박영년, 송시영, 최준정대한병리학회 · Journal of Pathology and Translational Medicine2009 · 제43권 제5호Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer김현기, 김호근, 노성훈, 배윤성거트앤리버 소화기연관학회협의회 · Gut and Liver2015 · 제9권 제5호Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes김아롱, 김주연, 김지연, 박도윤, 박원영, 신나리, 이창훈, 이현정, 허기영대한병리학회 · Journal of Pathology and Translational Medicine2013 · 제47권 제1호A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients김용범, 노재홍, Ala Aiob, Dong Hoon Suh, Duck Woo Kim, Hyojin Kim, Kidong Kim, Kyoung Un Park, Soo Hyun Seo, Yeo Rae Kim대한산부인과학회 · Obstetrics & Gynecology Science2023 · 제66권 제6호

이 간행물의 다른 논문 (14건)